Literature DB >> 34341181

Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.

Gemma D Banham1,2, Alexandra Godlee2,3, Sian E Faustini4, Adam F Cunningham4, Alex Richter2,4, Lorraine Harper5,6.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody; hemodialysis

Mesh：

Substances：

Year:  2021        PMID： 34341181      PMCID： PMC8729838          DOI： 10.1681/ASN.2021020188

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  6 in total

Review 1.  Aspects of immune dysfunction in end-stage renal disease.

Authors:  Sawako Kato; Michal Chmielewski; Hirokazu Honda; Roberto Pecoits-Filho; Seiichi Matsuo; Yukio Yuzawa; Anders Tranaeus; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

2.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Authors:  Jennifer M Dan; Jose Mateus; Yu Kato; Kathryn M Hastie; Esther Dawen Yu; Caterina E Faliti; Alba Grifoni; Sydney I Ramirez; Sonya Haupt; April Frazier; Catherine Nakao; Vamseedhar Rayaprolu; Stephen A Rawlings; Bjoern Peters; Florian Krammer; Viviana Simon; Erica Ollmann Saphire; Davey M Smith; Daniela Weiskopf; Alessandro Sette; Shane Crotty
Journal:  Science       Date:  2021-01-06       Impact factor: 47.728

3.  Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients.

Authors:  A M Cook; S E Faustini; L J Williams; A F Cunningham; M T Drayson; A M Shields; D Kay; L Taylor; T Plant; A Huissoon; G Wallis; S Beck; S E Jossi; M Perez-Toledo; M L Newby; J D Allen; M Crispin; S Harding; A G Richter
Journal:  J Immunol Methods       Date:  2021-03-26       Impact factor: 2.303

4.  Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis.

Authors:  Manuela Savino; Anna Casula; Shalini Santhakumaran; David Pitcher; Esther Wong; Winnie Magadi; Katharine M Evans; Fran Benoy-Deeney; James Griffin; Lucy Plumb; Retha Steenkamp; Dorothea Nitsch; James Medcalf
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

5.  Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.

Authors:  Ania Wajnberg; Fatima Amanat; Adolfo Firpo; Deena R Altman; Mark J Bailey; Mayce Mansour; Meagan McMahon; Philip Meade; Damodara Rao Mendu; Kimberly Muellers; Daniel Stadlbauer; Kimberly Stone; Shirin Strohmeier; Viviana Simon; Judith Aberg; David L Reich; Florian Krammer; Carlos Cordon-Cardo
Journal:  Science       Date:  2020-10-28       Impact factor: 47.728

6.  Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

Authors:  Sheila F Lumley; Denise O'Donnell; Nicole E Stoesser; Philippa C Matthews; Alison Howarth; Stephanie B Hatch; Brian D Marsden; Stuart Cox; Tim James; Fiona Warren; Liam J Peck; Thomas G Ritter; Zoe de Toledo; Laura Warren; David Axten; Richard J Cornall; E Yvonne Jones; David I Stuart; Gavin Screaton; Daniel Ebner; Sarah Hoosdally; Meera Chand; Derrick W Crook; Anne-Marie O'Donnell; Christopher P Conlon; Koen B Pouwels; A Sarah Walker; Tim E A Peto; Susan Hopkins; Timothy M Walker; Katie Jeffery; David W Eyre
Journal:  N Engl J Med       Date:  2020-12-23       Impact factor: 91.245
  6 in total
  5 in total

1.  Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination.

Authors:  Louise Benning; Christian Morath; Marie Bartenschlager; Christian Nusshag; Florian Kälble; Mirabel Buylaert; Matthias Schaier; Jörg Beimler; Katrin Klein; Julia Grenz; Paula Reichel; Asa Hidmark; Gerald Ponath; Maximilian Töllner; Marvin Reineke; Susanne Rieger; Burkhard Tönshoff; Paul Schnitzler; Martin Zeier; Caner Süsal; Ralf Bartenschlager; Claudius Speer
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-22       Impact factor: 8.237

Review 2.  Immune responses to SARS-CoV-2 in dialysis and kidney transplantation.

Authors:  Chiara Cantarelli; Andrea Angeletti; Laura Perin; Luis Sanchez Russo; Gianmarco Sabiu; Manuel Alfredo Podestà; Paolo Cravedi
Journal:  Clin Kidney J       Date:  2022-07-27

Review 3.  COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.

Authors:  Khalil El Karoui; An S De Vriese
Journal:  Kidney Int       Date:  2022-02-14       Impact factor: 18.998

4.  A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.

Authors:  Hiroko Beppu; Toshie Ogawa; Masahiro Ishikane; Tomoko Kawanishi; Tatsuya Fukuda; Lubuna Sato; Akihiro Matsunaga; Kenji Maeda; Daisuke Katagiri; Yukihito Ishizaka; Hiroaki Mitsuya; Norio Ohmagari; Fumihiko Yasui; Michinori Kohara; Kan Kikuchi; Sachiko Wakai
Journal:  CEN Case Rep       Date:  2022-03-09

5.  Dynamics of SARS-CoV-2 exposure in Malawian infants between February 2020 and May 2021.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Stefano Orlando; Robert Mphwere; Thom Kavalo; Richard Luhanga; Roberta Amici; Marco Floridia; Mauro Andreotti; Paola Scarcella; Maria Cristina Marazzi; Marina Giuliano
Journal:  J Clin Virol Plus       Date:  2022-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.